07:00 , Jul 20, 2015 |  BC Week In Review  |  Company News

amp biosimilars deal

amp granted an undisclosed Chinese pharmaceutical company exclusive, Chinese rights to ABY-018. The humanized mAb is a biosimilar of an undisclosed cancer product. The undisclosed company will fund development after the preclinical testing and...